Listed by the USPTO as SCHUBERG, LAURA J
Tech Center 3700 • Art Units: 1631 1632 1633 1657 1743 1799 3774
This examiner grants 24% of resolved cases
SCHUBERG, LAURA J is assigned to Tech Center 3700 and Art Unit 1631. Across 543 resolved cases, the allowance rate is 23.6%, the interview lift is 37.0%, and the median time to allowance is 1615 days. The record combines a low allowance level with a notable interview measure and a lengthy median prosecution period.
The listed companies are Wisconsin Alumni Research Foundation, The University of North Carolina at Chapel Hill, and Regeneron Pharmaceuticals Inc. The leading firms are FOLEY & LARDNER LLP, NORTON ROSE FULBRIGHT US LLP, and Casimir Jones, S.C. Applicants may need careful claim positioning and purposeful interviews to address examination obstacles.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16596495 | COMPOSITIONS AND METHODS FOR OBTAINING STEM CELL DERIVED LUNG TISSUE, AND RELATED USES THEROF | Non-Final OA | The Regents of the University of Michigan |
| 18020419 | DISSOLVABLE GELATIN-BASED MICROCARRIERS GENERATED THROUGH DROPLET MICROFLUIDICS FOR EXPANSION AND CULTURE OF MESENCHYMAL STROMAL CELL | Non-Final OA | Massachusetts Institute of Technology |
| 19042945 | IFNy AND TNFa CO-STIMULATION OF MESENCHYMAL STROMAL CELLS DERIVED FROM MINOR SALIVARY (LABIAL) GLANDS FOR THERAPEUTIC USE | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18819158 | Generating Vasculogenic Cell Populations | Non-Final OA | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 18463211 | REAGENTS AND METHODS FOR PRODUCING ERYTHROMYELOID PROGENITOR CELLS, NK CELLS, AND MEGAKARYOCYTES | Final Rejection | Wisconsin Alumni Research Foundation |
| 18484137 | ENGINEERED VASCULAR TISSUE MODELS | Non-Final OA | The Johns Hopkins University |
| 18924826 | MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18705362 | METHOD FOR PRODUCING MILK LIKE PRODUCTS | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 16984531 | METABOLICALLY OPTIMIZED CELL CULTURE | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 15130780 | METABOLICALLY OPTIMIZED CELL CULTURE | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 17352135 | SYSTEMS AND METHODS FOR MIMICKING A BLOOD VESSEL OF A PATIENT | Final Rejection | The Texas A&M University System |
| 17608008 | CELL CULTURING SCAFFOLDING MATERIAL AND CELL CULTURING VESSEL | Non-Final OA | SEKISUI CHEMICAL CO., LTD. |
| 19050638 | TISSUE DECONTAMINATION AND PRESERVATION SYSTEM | Non-Final OA | The Curators of the University of Missouri |
| 18608445 | FUNCTIONAL HYDROGEL BIO-INK MODIFIED WITH BOROPHOSPHATE GLASSES | Final Rejection | THE CURATORS OF THE UNIVERSITY OF MISSOURI |
| 18835286 | METHOD FOR PRODUCING LUNG MESENCHYMAL CELLS AND LUNG MESENCHYMAL CELLS | Non-Final OA | KYOTO UNIVERSITY |
| 18482096 | STIFFNESS TUNABLE BIOMIMETIC DECELLULARIZED EXTRACELLULAR MATRIX-BASED MATERIAL SYSTEMS | Non-Final OA | The Trustees of the University of Pennsylvania |
| 19044070 | LACTOBACILLI FOR TREATING CARDIAC DYSFUNCTION | Non-Final OA | INTERNATIONAL N&H DENMARK APS |
| 18784235 | Organoid Compositions | Non-Final OA | OSAKA UNIVERSITY |
| 16078002 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | Non-Final OA | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
| 18566110 | COMPOSITION CONTAINING FEEDER CELL FOR PROLIFERATING NATURAL KILLER CELL | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 18287435 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PARKINSON'S DISEASE, AND PREPARATION METHOD THEREOF | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 18012743 | SELF-ASSEMBLED CELL SHEET CONSTRUCTS AND METHODS OF MAKING THEREOF | Final Rejection | Caro Meats Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy23.6% of resolved applications examined by Laura J Schuberg were allowed (543 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +37.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Laura J Schuberg took 1,615 days on average from filing to allowance.
Laura J Schuberg examines applications in Art Unit 1631 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
